104 related articles for article (PubMed ID: 3938023)
1. [Possibilities of liver damage by foreign substances].
Bien E
Pharmazie; 1985 Nov; 40(11):815-20. PubMed ID: 3938023
[No Abstract] [Full Text] [Related]
2. [Drug-induced hepatits: the role of unstable metabolites (author's transl)].
Pessayre D; Benhamou JP
Acta Gastroenterol Belg; 1978; 41(9-10):574-86. PubMed ID: 735686
[No Abstract] [Full Text] [Related]
3. Influence of isoniazid, phenobarbital, phenytoin, pregnenolone 16-alpha carbonitrile, and beta-naphthoflavone on halothane metabolism and hepatotoxicity.
Jenner MA; Plummer JL; Cousins MJ
Drug Metab Dispos; 1990; 18(5):819-22. PubMed ID: 1981743
[No Abstract] [Full Text] [Related]
4. Metabolic activation: biochemical basis for many drug-induced liver injuries.
Mitchell JR; Nelson SD; Thorgeirsson SS; McMurtry RJ; Dybing E
Prog Liver Dis; 1976; 5():259-79. PubMed ID: 775543
[No Abstract] [Full Text] [Related]
5. Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage.
Sotaniemi EA; Hokkanen OT; Ahokas JT; Pelkonen RO; Ahlqvist J
Eur J Clin Pharmacol; 1977 Dec; 12(6):429-35. PubMed ID: 598417
[No Abstract] [Full Text] [Related]
6. [Reactive metabolites of xenobiotics : their role in the hepatotoxicity of drugs].
Pessayre D; Benhamou JP
C R Seances Soc Biol Fil; 1979; 173(2):458-68. PubMed ID: 159767
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis.
Dybing E; Nelson SD; Mitchell JR; Sasame HA; Gillette JR
Mol Pharmacol; 1976 Nov; 12(6):911-20. PubMed ID: 187927
[No Abstract] [Full Text] [Related]
8. The 1980 Bernard B. Brodie award lecture. Drug metabolism by cytochrome P-450: progress and perspectives.
Coon MJ
Drug Metab Dispos; 1981; 9(1):1-4. PubMed ID: 6111423
[No Abstract] [Full Text] [Related]
9. [Biochemical mechanisms of prostaglandin synthetase co-oxidation of xenobiotics (review)].
Golovenko NIa; Galkin BN
Vopr Med Khim; 1986; 32(3):9-15. PubMed ID: 3088836
[No Abstract] [Full Text] [Related]
10. [Recent findings on the hepatotoxicity of drugs].
Altomare E; Vendemiale G; Stufano N; Di Monte D; Procacci V; Albano O
Recenti Prog Med; 1985 Nov; 76(11):598-605. PubMed ID: 3912875
[No Abstract] [Full Text] [Related]
11. Experimental in vitro approach to the study of covalent associations.
Pantarotto C
Food Addit Contam; 1984; 1(2):131-46. PubMed ID: 6536525
[No Abstract] [Full Text] [Related]
12. [Drug induced liver injury. Chemical liver necrosis caused by formation of reactive metabolites].
Dybing E
Tidsskr Nor Laegeforen; 1976 Feb; 96(4):220-1. PubMed ID: 1251392
[No Abstract] [Full Text] [Related]
13. Xenobiotic metabolism by prostaglandin endoperoxide synthetase.
Eling T; Boyd J; Reed G; Mason R; Sivarajah K
Drug Metab Rev; 1983; 14(5):1023-53. PubMed ID: 6418501
[No Abstract] [Full Text] [Related]
14. Role of nutrition in the drug-metabolizing enzyme system.
Campbell TC; Hayes JR
Pharmacol Rev; 1974 Sep; 26(3):171-97. PubMed ID: 4142091
[No Abstract] [Full Text] [Related]
15. Drugs in liver disease.
Branch RA
Clin Pharmacol Ther; 1998 Oct; 64(4):462-5. PubMed ID: 9797803
[No Abstract] [Full Text] [Related]
16. Interactions of drug metabolites with hepatic cytochrome P-450. Some implications for drug metabolism.
Bast A
Pharm Weekbl Sci; 1982 Aug; 4(4):113-4. PubMed ID: 7133961
[No Abstract] [Full Text] [Related]
17. [Hepatic metabolism of foreign substances. Enzymatic hydroxylation system of hepatic microsomes and of cytochrome P-450].
Valla D
Med Chir Dig; 1978; 7(3):259-62, 265-6. PubMed ID: 28455
[No Abstract] [Full Text] [Related]
18. Editorial: Promising approaches to identify DILI drugs.
Li AP; Zhang J
Chem Biol Interact; 2016 Aug; 255():1-2. PubMed ID: 27393768
[No Abstract] [Full Text] [Related]
19. Carbon tetrachloride hepatotoxicity: an example of lethal cleavage.
Rechnagel RO; Glende EA
CRC Crit Rev Toxicol; 1973 Nov; 2(3):263-97. PubMed ID: 4357489
[No Abstract] [Full Text] [Related]
20. [Significance of enzyme activity in pyrimidine biosynthesis for the development of galactosamine liver lesions].
Pausch J; Keppler D; Decker K
Verh Dtsch Ges Inn Med; 1972; 78():1375-7. PubMed ID: 4665550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
